Evidence map›Paper›PMID 30784040›Full record

Trial reportHeadache2019

Cross-Sectional Evaluation of the Psychometric Properties of the Headache-Specific Locus of Control Scale in People With Migraine.

Amy S Grinberg, Elizabeth K Seng

Abstract readPragmatic Clinical TrialRandomized Controlled Trial
In one paragraph

Trial report in Headache, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Amy S GrinbergVA Connecticut Healthcare System, West Haven, CT, USA.ORCID 0000-0003-4141-9513
Elizabeth K SengFerkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, USA.ORCID 0000-0002-8938-4949

Funding

MULTICENTER STUDY OF EPILEPSY SURGERYR01NS032375 · NINDS · YALE UNIVERSITY · PI SPENCER, SUSAN S · 1996 to 2005
$7.7M
DRUG AND NON-DRUG TREATMENT OF SEVERE MIGRAINESR01NS032374 · NINDS · OHIO UNIVERSITY ATHENS · PI HOLROYD, KENNETH ALLEN · 1994 to 2004
$2.7M
Clinical Decision Support for Patient Migraine ManagementK23NS096107 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SENG-TAMACCIO, ELIZABETH K · 2016 to 2020
$965k
Tailored Messaging and Behavioral Treatment for MigraineK23NS048288 · NINDS · SAINT LOUIS UNIVERSITY · PI NICHOLSON, ROBERT A · 2006 to 2010
$786k
GlaxoSmithKline PharmaceuticalsInternational Headache AcademyMerck Pharmaceuticals, Inc.NINDS NIH HHS K23 NS048288NINDS NIH HHS K23 NS096107NINDS NIH HHS R01 NS032374NINDS NIH HHS R01 NS032375The National Institute of Neurological Disorders and Stroke NS-048288The National Institute of Neurological Disorders and Stroke NS-32375Yeshiva University
6 · The paper itself

Abstract

objectiveThis study aims to investigate the psychometric properties (component structure, reliability, and construct validity) of the Headache-Specific Locus of Control scale in several clinical migraine populations.

backgroundHeadache-specific locus of control beliefs may impact a person's behavioral decisions that affect the likelihood of migraine attack onset, emotional responses to migraine attacks, coping strategies used, and treatment adherence. The 33-item Headache-Specific Locus of Control scale is the most widely used measure of locus of control specific to headache yet psychometric evaluations remain limited.

methodsSix hundred and ninety-five adults with a diagnosis of migraine from 5 different research studies completed cross-sectional self-report measures including the Headache-Specific Locus of Control scale and measures of quality of life and disability (Migraine-Specific Quality of Life Questionnaire and Migraine Disability Assessment).

resultsFive Headache-Specific Locus of Control components emerged from Horn's Parallel Analysis, Minimum Average Partial test, and Principal Component Analysis (eigenvalues: Presence of Internal = 5.7, Lack of Internal = 4.0, Luck = 2.9, Doctor = 2.0, and Treatment = 1.5). The 33 Headache-Specific Locus of Control items demonstrated adequate internal consistency for total (α = 0.79) and subscale scores (α's = 0.69 to 0.88). This study found preliminary evidence of convergent validity. For example, Lack of Internal (r = -0.12, P = 0.004), Doctor (r = -0.20, P < .001), and Treatment (r = -0.12, P = .004) beliefs were associated with higher overall migraine-specific quality of life impairments.

conclusionsThe Headache-Specific Locus of Control scale is a reliable and valid measure of headache-specific locus of control. Findings suggest that headache-specific locus of control is more multidimensional than previous conceptualizations and contribute to our understanding of control beliefs as a potential mechanism for migraine treatment.

Indexed as

Adaptation, PsychologicalAdultBehavior TherapyCross-Sectional StudiesFemaleHeadacheHumansMaleMiddle AgedMigraine DisordersMindfulnessPsychometricsQuality of LifeSelf Reportbeliefsdisabilitylocus of controlmigrainequality of life

Identifiers

PMID30784040
PMCPMC6488432

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.